Atea Pharmaceuticals Inc.
Organization details
- Legal name
- Atea Pharmaceuticals Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Massachusetts
- Headquarters city
- Boston
- Headquarters state / province
- Massachusetts
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- AVIR
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001593899
- EIN
- 46-0574869
Board of directors
-
Arthur S. Kirsch · DirectorSince 2025
-
Barbara Gayle Duncan · DirectorSince 2023
-
Bruce Polsky · DirectorSince 2023
-
Bruno Lucidi · DirectorSince 2023
-
Franklin M. Berger · DirectorSince 2023
-
Howard Berman · DirectorSince 2025
-
Jean-Pierre Sommadossi · Director · President, CEO, and ChairmanSince 2023
-
Jerome M. Adams · DirectorSince 2023
-
Polly A. Murphy · DirectorSince 2023
Chief executives
Director election results
Annual meeting of June 18, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
85.6%
-
87.1%
Board connections
5 of this board's directors also sit on 7 other boards. 7 are in the same sector.
-
Celcuity Inc. Same sectorvia Polly A. Murphy
-
Coya Therapeutics Inc. Same sectorvia Howard Berman
-
Evommune Inc. Same sectorvia Arthur S. Kirsch
-
Halozyme Therapeutics Inc. Same sectorvia Barbara Gayle Duncan
-
Liquidia Corporation Same sectorvia Arthur S. Kirsch
-
Ovid Therapeutics Inc. Same sectorvia Barbara Gayle Duncan
-
Retension Pharmaceuticals Inc. Same sectorvia Franklin M. Berger
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 18, 2026 | Bruno Lucidi Director | Option exercise | +29,600 | — | — |
| Jun 18, 2026 | Franklin M. Berger Director | Option exercise | +29,600 | — | — |
| Jun 18, 2026 | Barbara Gayle Duncan Director | Option exercise | +29,600 | — | — |
| Jun 18, 2026 | Jerome M. Adams Director | Option exercise | +29,600 | — | — |
| Jun 18, 2026 | Bruce Polsky Director | Option exercise | +29,600 | — | — |
| Jun 18, 2026 | Polly A. Murphy Director | Option exercise | +29,600 | — | — |
| Mar 11, 2026 | Corcoran Andrea Officer (See Remarks) | Option exercise | +60,000 | $1.24 | $74,400 |
| Feb 3, 2026 | Jean-Pierre Sommadossi Director, Officer (President, CEO, and Chairman) | Option exercise | +300,000 | $1.24 | $372,000 |
| Jan 31, 2026 | Horga Maria Arantxa Officer (Chief Medical Officer) | Option exercise | +51,283 | — | — |
| Jan 31, 2026 | Vavricka John Officer (Chief Commercial Officer) | Option exercise | +42,083 | — | — |
| Jan 31, 2026 | Hammond Janet MJ Officer (Chief Development Officer) | Option exercise | +58,050 | — | — |
| Jan 31, 2026 | Corcoran Andrea Officer (See Remarks) | Option exercise | +54,866 | — | — |
| Jan 31, 2026 | Jean-Pierre Sommadossi Director, Officer (President, CEO, and Chairman) | Option exercise | +272,983 | — | — |
| Jan 31, 2026 | Foster Wayne Officer (EVP, Chief Accounting Officer) | Option exercise | +41,333 | — | — |
| Jan 31, 2026 | Horga Maria Arantxa Officer (Chief Medical Officer) | Shares withheld for tax | −16,073 | $4.24 | $68,150 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Atea Pharmaceuticals Inc.
Who is the CEO of Atea Pharmaceuticals Inc.?
Jean-Pierre Sommadossi is Atea Pharmaceuticals Inc.'s President, CEO, and Chairman.
How many directors are on Atea Pharmaceuticals Inc.'s board?
Atea Pharmaceuticals Inc.'s board has 9 directors: Arthur S. Kirsch, Barbara Gayle Duncan, Bruce Polsky, Bruno Lucidi, Franklin M. Berger, Howard Berman, Jean-Pierre Sommadossi, Jerome M. Adams and Polly A. Murphy.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="atea-pharmaceuticals-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.